Selinexor-based regimens for the treatment of myeloma refractory to chimeric antigen receptor T cell therapy.
Ajai ChariDan T VoglSundar JagannathJagoda JasielecThaddeus J UngerAndrew DeCastroJatin ShahMichael KauffmanSharon ShachamAndrzej J JakubowiakPublished in: British journal of haematology (2020)